Alignment Healthcare, Inc. (ALHC) vs Xeris Biopharma Holdings, Inc. (XERS)
A side-by-side comparison of Alignment Healthcare, Inc. and Xeris Biopharma Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALHC
Alignment Healthcare, Inc.
$8.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XERS
Xeris Biopharma Holdings, Inc.
$10.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALHC vs XERS
growth of $100 · dividends reinvested · last 6yALHC -50.9% (-11.2%/yr)XERS +138.4% (+15.6%/yr)XERS compounded faster over this window
ALHC XERS
ALHC vs XERS: by the numbers
- •XERS is the larger company ($1.74B vs $1.74B market cap).
- •ALHC is profitable (0.89% net margin) while XERS runs a net loss (-5.12%).
- •XERS grew revenue faster over the past five years (58.33% vs 33.83% CAGR).
Metrics side by side
Valuation
| Metric | ALHC | XERS |
|---|---|---|
| P/E ratio | 44.86 | N/A |
| Forward P/E | 46.10 | N/A |
| P/S ratio | 0.38 | 5.18 |
| P/B ratio | 6.55 | N/A |
| EV / EBITDA | 15.87 | 38.84 |
| FCF yield | N/A | 3.19% |
Profitability
| Metric | ALHC | XERS |
|---|---|---|
| Gross margin | 12.55% | 83.34% |
| Operating margin | 1.20% | 10.91% |
| Net margin | 0.89% | -5.12% |
| ROE | 15.35% | N/A |
| ROIC | 9.23% | 12.79% |
Growth (annualized)
| Metric | ALHC | XERS |
|---|---|---|
| Revenue CAGR (5Y) | 33.83% | 58.33% |
| Total return CAGR (5Y) | -12.15% | 33.72% |
Frequently asked
- Which has grown faster, ALHC or XERS?
- Over the past five years, XERS grew revenue faster — ALHC at a 33.83% CAGR versus XERS at 58.33%.
- Is ALHC or XERS more profitable?
- ALHC runs the higher net margin — ALHC at 0.89% versus XERS at -5.12%.
- How have ALHC and XERS total returns compared?
- Over the past 5 years, ALHC delivered -12.15% and XERS delivered 33.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alignment Healthcare P/E ratioAlignment Healthcare ROEXeris Biopharma ROEAlignment Healthcare operating marginXeris Biopharma operating marginAlignment Healthcare revenue growthXeris Biopharma revenue growthAlignment Healthcare free cash flowXeris Biopharma free cash flow
Alignment Healthcare & Xeris Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.